EUVIMEDEUVIMED entdecken
Crossref

Synthesis, in silico and in vitro studies of hydrazide‐hydrazone imine derivatives as potential cholinesterase inhibitors

Seyit Ali Güngör

Chemical Biology & Drug Design · 2023-10 · 102 (4) · 676-691

DOI: 10.1111/cbdd.14274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 31.05.2023. Verfasst von Seyit Ali Güngör. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Kahramanmaras Sütcü Imam University, Kahramanmaras, Turkey. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Butyrylcholinesterase. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of hydrazide‐hydrazone imine derivative compounds (3a–k) were synthesized and their structures characterized using FTIR, 1 H, and 13 C (NMR) spectroscopic methods. In addition, molecular structures of compounds 3a, 3d, and 3g were elucidated by X‐ray diffraction technique. In vitro inhibition activities of hydrazide‐hydrazone imine derivatives against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) were investigated. Compound 3i (IC 50 = 2.01 μM) exhibited the best inhibitory activity against AChE, comparable to the control Galantamine (IC 50 = 2.60 μM). Against BChE, compound 3h (IC 50 = 2.83 μM) showed the best inhibitory property which is higher control Galantamine (IC 50 = 3.70 μM). The Ki values of compound 3i (Ki = 0.63 μM) and compound 3h (Ki = 0.94 μM) that have the strongest inhibitory potential were determined against AChE and BChE, respectively. According to the docking result, the most stable conformation of AChE and compound 3i showed that it has a binding affinity of −10.82 kcal/moL. The binding affinity of the most stable conformation formed by BChE and compound 3h is −8.60 kcal/moL. Finally, in silico results and pharmacokinetic parameters of ADME showed that these compounds have good oral bioavailability properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsButyrylcholinesteraseAcetylcholinesteraseHydrazonesHydrazinesGalantamineStructure-Activity RelationshipMolecular Docking SimulationMolecular Structure

Stichwörter der Autor:innen

ADMEcholinesterasehydrazide-hydrazoneinhibitorsmolecular docking

Substanzen

Cholinesterase InhibitorsButyrylcholinesteraseAcetylcholinesteraseHydrazonesHydrazinesGalantamine

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Kahramanmaras Sütcü Imam University, Kahramanmaras, Turkey.

Zitieren

APA

Güngör, S. A. (2023). Synthesis, in silico and in vitro studies of hydrazide‐hydrazone imine derivatives as potential cholinesterase inhibitors. Chemical Biology & Drug Design, 102(4), 676-691. https://doi.org/10.1111/cbdd.14274

Vancouver

Güngör SA. Synthesis, in silico and in vitro studies of hydrazide‐hydrazone imine derivatives as potential cholinesterase inhibitors. Chemical Biology & Drug Design. 2023;102(4):676-691. doi:10.1111/cbdd.14274

BibTeX
@article{Gngr2023,
  author = {Güngör, Seyit Ali},
  title = {Synthesis, in silico and in vitro studies of hydrazide‐hydrazone imine derivatives as potential cholinesterase inhibitors},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  volume = {102},
  number = {4},
  pages = {676--691},
  doi = {10.1111/cbdd.14274}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche